Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
Status: Enrolling
Updated:  2/18/2016
Department of Ophthalmology, New York Hospital-Cornell Medical Center
mi
from
New York, NY
Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
Status: Enrolling
Updated: 2/18/2016
Department of Ophthalmology, New York Hospital-Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
Status: Enrolling
Updated:  2/18/2016
Department of Ophthalmology, Mount Sinai School of Medicine
mi
from
New York, NY
Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
Status: Enrolling
Updated: 2/18/2016
Department of Ophthalmology, Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
Status: Enrolling
Updated:  2/18/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
Status: Enrolling
Updated: 2/18/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
Status: Enrolling
Updated:  2/18/2016
Cullen Eye Institute, Baylor College of Medicine
mi
from
Houston, TX
Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
Status: Enrolling
Updated: 2/18/2016
Cullen Eye Institute, Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Genetic Assessment of Early to Late Macular Degeneration Study
Genetic Assessment of Early to Late macuLar dEgeneration studY 2
Status: Enrolling
Updated:  2/18/2016
The University of California, San Diego
mi
from
La Jolla, CA
Genetic Assessment of Early to Late Macular Degeneration Study
Genetic Assessment of Early to Late macuLar dEgeneration studY 2
Status: Enrolling
Updated: 2/18/2016
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Genetic Assessment of Early to Late Macular Degeneration Study
Genetic Assessment of Early to Late macuLar dEgeneration studY 2
Status: Enrolling
Updated:  2/18/2016
California Retina Consultants
mi
from
Santa Barbara, CA
Genetic Assessment of Early to Late Macular Degeneration Study
Genetic Assessment of Early to Late macuLar dEgeneration studY 2
Status: Enrolling
Updated: 2/18/2016
California Retina Consultants
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Genetic Assessment of Early to Late Macular Degeneration Study
Genetic Assessment of Early to Late macuLar dEgeneration studY 2
Status: Enrolling
Updated:  2/18/2016
Medical Center Ophthalmology Associates
mi
from
San Antonio, TX
Genetic Assessment of Early to Late Macular Degeneration Study
Genetic Assessment of Early to Late macuLar dEgeneration studY 2
Status: Enrolling
Updated: 2/18/2016
Medical Center Ophthalmology Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
Intraocular Pressure During Spine Surgery
The Effect of Lactated Ringer's Solution Versus Albumin and the Alpha-2 Agonist Brimonidine Versus Placebo on Intraocular Pressure During Prone Spine Surgery
Status: Enrolling
Updated:  2/19/2016
Cleveland Clinic
mi
from
Cleveland, OH
Intraocular Pressure During Spine Surgery
The Effect of Lactated Ringer's Solution Versus Albumin and the Alpha-2 Agonist Brimonidine Versus Placebo on Intraocular Pressure During Prone Spine Surgery
Status: Enrolling
Updated: 2/19/2016
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Levodopa for the Treatment of Residual Amblyopia
A Randomized Trial of Levodopa as Treatment for Residual Amblyopia (ATS 17)
Status: Enrolling
Updated:  2/22/2016
Wilmer Eye Institute
mi
from
Baltimore, MD
Levodopa for the Treatment of Residual Amblyopia
A Randomized Trial of Levodopa as Treatment for Residual Amblyopia (ATS 17)
Status: Enrolling
Updated: 2/22/2016
Wilmer Eye Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated:  2/22/2016
Huntington Memorial Hospital
mi
from
Pasadena, CA
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated: 2/22/2016
Huntington Memorial Hospital
mi
from
Pasadena, CA
Click here to add this to my saved trials
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated:  2/22/2016
Presbyterian/St Luke's Hospital
mi
from
Denver, CO
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated: 2/22/2016
Presbyterian/St Luke's Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated:  2/22/2016
OSF St. Francis Medical Center-Children's Hospital of Illinois
mi
from
Peoria, IL
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated: 2/22/2016
OSF St. Francis Medical Center-Children's Hospital of Illinois
mi
from
Peoria, IL
Click here to add this to my saved trials
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated:  2/22/2016
Palmetto Health Richland Hospital
mi
from
Columbia, SC
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated: 2/22/2016
Palmetto Health Richland Hospital
mi
from
Columbia, SC
Click here to add this to my saved trials
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated:  2/22/2016
Palmetto Health Baptist Hospital
mi
from
Columbia, SC
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated: 2/22/2016
Palmetto Health Baptist Hospital
mi
from
Columbia, SC
Click here to add this to my saved trials
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated:  2/22/2016
Driscoll Children's Hospital
mi
from
Corpus Christi, TX
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated: 2/22/2016
Driscoll Children's Hospital
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated:  2/22/2016
Baylor University Medical Center
mi
from
Dallas, TX
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated: 2/22/2016
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated:  2/22/2016
Las Palmas Medical Center
mi
from
El Paso, TX
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated: 2/22/2016
Las Palmas Medical Center
mi
from
El Paso, TX
Click here to add this to my saved trials
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated:  2/22/2016
R.E. Thomason Hospital
mi
from
El Paso, TX
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated: 2/22/2016
R.E. Thomason Hospital
mi
from
El Paso, TX
Click here to add this to my saved trials
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated:  2/22/2016
Del Sol Medical Center
mi
from
El Paso, TX
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated: 2/22/2016
Del Sol Medical Center
mi
from
El Paso, TX
Click here to add this to my saved trials
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated:  2/22/2016
Cook Children's Medical Center
mi
from
Fort Worth, TX
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated: 2/22/2016
Cook Children's Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated:  2/22/2016
St. Joseph Medical Center
mi
from
Houston, TX
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated: 2/22/2016
St. Joseph Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated:  2/22/2016
Children's Memorial Hermann Hospital
mi
from
Houston, TX
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated: 2/22/2016
Children's Memorial Hermann Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated:  2/22/2016
Memorial Hermann Southwest Hospital
mi
from
Houston, TX
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated: 2/22/2016
Memorial Hermann Southwest Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated:  2/22/2016
Clear Lake Regional Medical Center
mi
from
Webster, TX
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Status: Enrolling
Updated: 2/22/2016
Clear Lake Regional Medical Center
mi
from
Webster, TX
Click here to add this to my saved trials
POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle Glaucoma
An Open-label Comparison of the Safety and Efficacy of Subconjunctival Liposomal Latanoprost (POLAT-001) to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Primary Open Angle Glaucoma
Status: Enrolling
Updated:  2/23/2016
Professional Research Network
mi
from
Goose Creek, SC
POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle Glaucoma
An Open-label Comparison of the Safety and Efficacy of Subconjunctival Liposomal Latanoprost (POLAT-001) to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Primary Open Angle Glaucoma
Status: Enrolling
Updated: 2/23/2016
Professional Research Network
mi
from
Goose Creek, SC
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Boston, MA
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Fayetteville, AR
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Orange, CA
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
San Diego, CA
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Denver, CO
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Ft. Collins, CO
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Ft. Collins, CO
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Boynton Beach, FL
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Ft. Myers, FL
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Ft. Myers, FL
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Atlanta, GA
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Sioux City, IA
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Sioux City, IA
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Garden City, KA
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Garden City, KA
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
St. Louis, MO
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Vineland, NJ
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Vineland, NJ
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Kingston, PA
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Kingston, PA
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Knoxville, TN
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Nashville, TN
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
mi
from
Dallas/Ft. Worth, TX
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
mi
from
Dallas/Ft. Worth, TX
Click here to add this to my saved trials
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
San Antonio, TX
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis
Phase 2 EFFICACY AND SAFETY OF HYDROCORTISONE OPHTHALMIC OINTMENT - VERSUS PLACEBO IN THE TREATMENT OF ALLERGIC CONJUNCTIVITIS
Status: Enrolling
Updated:  2/24/2016
Koffler Vision Group
mi
from
Lexington, KY
Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis
Phase 2 EFFICACY AND SAFETY OF HYDROCORTISONE OPHTHALMIC OINTMENT - VERSUS PLACEBO IN THE TREATMENT OF ALLERGIC CONJUNCTIVITIS
Status: Enrolling
Updated: 2/24/2016
Koffler Vision Group
mi
from
Lexington, KY
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Steven S. Grant, OD
mi
from
Costa Mesa, CA
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Steven S. Grant, OD
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Cole, Cole, and Krohn
mi
from
Fresno, CA
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Cole, Cole, and Krohn
mi
from
Fresno, CA
Click here to add this to my saved trials